Advertisement

Topics

Ligand???s Partner Melinta Announces U.S. FDA Approval Of Baxdela (Delafloxacin) For Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

20:00 EDT 19 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Ligand???s Partner Melinta Announces U.S. FDA Approval Of Baxdela (Delafloxacin) For Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

NEXT ARTICLE

More From BioPortfolio on "Ligand???s Partner Melinta Announces U.S. FDA Approval Of Baxdela (Delafloxacin) For Acute Bacterial Skin And Skin Structure Infections (ABSSSI)"

Advertisement
Quick Search
Advertisement
Advertisement